148 related articles for article (PubMed ID: 37424270)
1. Evaluation of the pharmacokinetic interactions and safety of atogepant coadministered with esomeprazole.
Boinpally R; Butler M; Rojo J; Borbridge L; Wangsadipura V; Papinska A
Pain Manag; 2023 Jun; 13(6):351-361. PubMed ID: 37424270
[TBL] [Abstract][Full Text] [Related]
2. Atogepant and sumatriptan: no clinically relevant drug-drug interactions in a randomized, open-label, crossover trial.
Boinpally R; Jakate A; Butler M; Periclou A
Pain Manag; 2022 May; 12(4):499-508. PubMed ID: 34898273
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Pharmacokinetic Interaction and Safety of Atogepant Co-Administered with Acetaminophen or Naproxen in Healthy Participants: A Randomized Trial.
Boinpally R; Spaventa J; Chen K; Butler M
Clin Drug Investig; 2021 Jun; 41(6):557-567. PubMed ID: 33948911
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Safety of Coadministered Atogepant and Topiramate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction Study.
Boinpally R; McGeeney D; Borbridge L; Trugman J
Clin Pharmacol Drug Dev; 2023 Oct; 12(10):1013-1021. PubMed ID: 37210713
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Pharmacokinetic Interaction and Safety of Ubrogepant Coadministered With Esomeprazole Magnesium.
Boinpally R; Lu K
Clin Pharmacol Drug Dev; 2022 Feb; 11(2):270-277. PubMed ID: 34811955
[TBL] [Abstract][Full Text] [Related]
6. Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants.
Ankrom W; Xu J; Vallee MH; Dockendorf MF; Armas D; Boinpally R; Min KC
J Clin Pharmacol; 2020 Sep; 60(9):1157-1165. PubMed ID: 32297990
[TBL] [Abstract][Full Text] [Related]
7. Phase Ib, open-label, fixed-sequence, drug-drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine.
Blumenfeld AM; Boinpally R; De Abreu Ferreira R; Trugman JM; Dabruzzo B; Ailani J; Lipton RB
Headache; 2023 Mar; 63(3):322-332. PubMed ID: 36602199
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
Choi Y; Han H; Shin D; Lim KS; Yu KS
Drug Des Devel Ther; 2015; 9():4127-35. PubMed ID: 26257511
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the pharmacokinetic interaction between esomeprazole (40 mg) and acetylsalicylic acid (325 mg) in healthy volunteers.
Niazi M; Andersson T; Nauclér E; Sundin M; Naesdal J
Int J Clin Pharmacol Ther; 2009 Sep; 47(9):564-9. PubMed ID: 19761715
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the pharmacokinetics of trazpiroben (TAK-906) in the presence and absence of the proton pump inhibitor esomeprazole.
Kaur Mukker J; Dukes G; Wang L; Huh S; Khudyakov P; Nishihara M; Chen C
Clin Transl Sci; 2022 May; 15(5):1281-1290. PubMed ID: 35218604
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Safety of Atogepant Co-administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction Study.
Boinpally R; Borbridge L; Wangsadipura V
Clin Pharmacol Drug Dev; 2024 May; ():. PubMed ID: 38702918
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the pharmacokinetic interaction between lesogaberan (AZD3355) and esomeprazole in healthy subjects.
Niazi M; Silberg DG; Miller F; Ruth M; Holmberg AA
Drugs R D; 2010; 10(4):243-51. PubMed ID: 21171670
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans.
Jakate A; Boinpally R; Butler M; Lu K; McGeeney D; Periclou A
Headache; 2020 Jul; 60(7):1340-1350. PubMed ID: 32573795
[TBL] [Abstract][Full Text] [Related]
14. Effects of CYP3A4 inhibition/induction and OATP inhibition on the pharmacokinetics of atogepant in healthy adults.
Boinpally R; Chen W; McGeeney D; Trugman JM
Pain Manag; 2023 Aug; ():. PubMed ID: 37650778
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Esomeprazole Magnesium After Single Oral Doses in Healthy Subjects: Bioequivalence Study and Food Effects.
Zhong XF; Zhou G; Xu SM; Li XM; Xu Y; Liu WL; Zhang YX; He LC; Shen QY; Xu PS
Clin Pharmacol Drug Dev; 2022 Nov; 11(11):1308-1313. PubMed ID: 35822412
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open-label crossover study.
Shin JS; Lee JY; Cho KH; Park HL; Kukulka M; Wu JT; Kim DY; Park SH
Aliment Pharmacol Ther; 2014 Sep; 40(5):548-61. PubMed ID: 25041486
[TBL] [Abstract][Full Text] [Related]
17. A Single Supratherapeutic Dose of Atogepant Does Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized, Single-Dose, Phase 1 Crossover Trial.
Boinpally R; McNamee B; Yao L; Butler M; McGeeney D; Borbridge L; Periclou A
Clin Pharmacol Drug Dev; 2021 Sep; 10(9):1099-1107. PubMed ID: 33942560
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic comparison study of a combination containing 500 mg of Naproxen and 20 mg of Esomeprazole: a randomized, single-dose, 2-way crossover, open-label study in healthy Korean men.
Choi HG; Jeon JY; Kwak SS; Kim H; Jin C; Im YJ; Kim EY; Wang HM; Kim Y; Lee SY; Kim MG
Clin Ther; 2015 Jan; 37(1):83-93. PubMed ID: 25482305
[TBL] [Abstract][Full Text] [Related]
19. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
20. Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults.
Min KC; Kraft WK; Bondiskey P; Colón-González F; Liu W; Xu J; Panebianco D; Mixson L; Dockendorf MF; Matthews CZ; Boinpally R
Clin Transl Sci; 2021 Mar; 14(2):599-605. PubMed ID: 33142014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
